Table 1 The correlation between CASC9 expression and OS clinical pathology
Characteristics | Number of patients | CASC9 Low expression (≤ median) | CASC9 High expression (> median) | P value |
|---|---|---|---|---|
Number | 30 | 14 | 16 | |
Ages(years) | 0.358 | |||
< 18 | 15 | 8 | 7 | |
≥ 18 | 15 | 6 | 9 | |
Gender | 0.509 | |||
Female | 14 | 7 | 7 | |
Male | 16 | 7 | 9 | |
Tumor size | 0.035 | |||
≤ 2 cm | 13 | 9 | 4 | |
> 2 cm | 17 | 5 | 12 | |
TMN stage | 0.014 | |||
I–II | 14 | 10 | 4 | |
III–IV | 16 | 4 | 12 | |
Lymphatic metastasis | 0.642 | |||
Yes | 15 | 7 | 8 | |
No | 15 | 7 | 8 |